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2-Microglobulin (2m), a key component of themajor histo-
compatibility class I complex, can aggregate into fibrils with
severe clinical consequences. As such, investigating the struc-
tural aspects of the formation of oligomeric intermediates of
2m and their subsequent progression toward fibrillar aggre-
gates is of great importance. However, 2m aggregates are chal-
lenging targets in structural biology, primarily due to their
inherent transient and heterogeneous nature. Herewe study the
oligomeric distributions and structures of the early intermedi-
ates of amyloidogenic 2m and its truncated variant N6-2m.
Weestablished compact oligomers for both variants by integrat-
ing advanced mass spectrometric techniques with available
electron microscopy maps and atomic level structures from
NMR spectroscopy and x-ray crystallography. Our results re-
vealed a stepwise assembly mechanism by monomer addition
and domain swapping for the oligomeric species of N6-2m.
The observed structural similarity and common oligomeriza-
tion pathway between the two variants is likely to enable N6-
2m to cross-seed 2m fibrillation and allow the formation of
mixed fibrils. We further determined the key subunit interac-
tions in N6-2m tetramer, revealing the importance of a
domain-swappedhingeregionforformationofhigherorderolig-
omers. Overall, we deliver new mechanistic insights into 2m
aggregation, paving the way for future studies on the mecha-
nisms and cause of amyloid fibrillation.
The major histocompatibility class I complex (MHC I) is
found on the cell surface of all nucleated cells and is responsible
for antigen presentation (1, 2).2-Microglobulin (2m)2 is a key
component of this complex. After its dissociation fromMHC I,
serum 2m is broken down in the kidney. The buildup of circu-
lating2m can result as a consequence of renal dysfunction and
long term hemodialysis. This leads to amyloid fibril deposition
in osteoarticular tissues and joint destruction in a condition
known as dialysis-related amyloidosis.
Amyloidogenic proteins such as 2m tend to self-assemble
into higher order oligomeric species through a complex aggre-
gation process, which can ultimately lead to the formation of
fibrils (3–6). Despite the clinical significance of amyloid forma-
tion, the principles governing the mechanisms for the aggrega-
tion process of 2m and related proteins remains largely
unknown, primarily due to the transient nature of intermedi-
ates on-pathway to fibril formation (7). Structural elucidation
of 2m oligomeric intermediates is, therefore, a challenging
task that is further complicated by the uncertainty in differen-
tiating between specific and nonspecific protein aggregates.
Despite these obstacles progress has been made most prom-
inently from techniques such as nuclear magnetic resonance
spectroscopy (NMR) (8), x-ray crystallography (9), atomic force
microscopy (10), cryo-electron microscopy (EM) (11), and
hydrogen/deuterium exchange (12) and by combining NMR
with mass spectrometry (MS) (13). MS in particular is well
suited for studying heterogeneous assembly intermediates,
including proteins populating multiple oligomeric states (14).
When coupled with ion mobility (IM), IM-MS allows the
separation of different conformational states of co-populated
oligomers (5, 15). IM-MS has been successfully employed to
investigate the structure and dynamics of amyloid assembly
intermediates revealing information on the aggregation pro-
cess of A40 and A42 complexes (15, 16) and more recently
human amylin (17). Structural insights have also been gained
for2m (18, 19) where IM-MS experiments suggested either an
elongated or more compact assembly mechanism for full-
length 2m under different solution conditions (20).
The integration of different experimental techniques with
modeling can provide powerful means to interrogate candidate
models of protein assemblies (21–25). In particular so-called
hybrid approaches, which combine information from comple-
mentary experiments, have shed light on complexes intractable
by single techniques, exemplified by the structural elucidation
of the nuclear pore complex (26), the 26S proteasome (27, 28),
and the eukaryotic translation initiation factor 3 (29, 30).
Here we used an integrative MS-based strategy for generat-
ing three-dimensional structural models of the oligomeric
assembly intermediates of N6-2m, a truncated 2m isoform
(11.1-kDa monomer). N6-2m makes up to 30% of amyloid
deposits extracted from dialysis-related amyloidosis patients
and can act as a seed for full-length 2m fibrillogenesis in vitro
(1). Contrary to full-length 2m, N6-2m is highly amyloido-
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genic at neutral pH, making it a convenient model for studying
2m aggregation under laboratory conditions (2). Furthermore,
the x-ray crystal structure of the dimeric intermediate built by
the self-association of two N6-2m monomers was recently
solved, and proposed as a building block for growing oligomers
on-pathway to fibril formation (1). In this structure domain-
swapping occurs through the so-called hinge region, which cor-
responds to two NHVTLSQ heptapeptides interacting in an
antiparallel fashion (1).
Using a combination of experimental and computational
techniques, we predict the structures and an early assembly
mechanism forN6-2m oligomers.We further compare olig-
omers of the truncated variant with those of the full-length
protein, highlighting similar oligomeric distributions and com-
pact topologies aswell as inter- and intraprotein distances. This
points to a common assembly mechanism in the early stages of
their aggregation and may facilitate the ability of the truncated
variant to cross-seed and form mixed fibrils (31) with full-
length 2m in vivo. The data and the structural models gener-
ated from the integrative strategy further suggest an elongation
mechanism of monomer addition consistent with domain
swapping and self-templated growth. Furthermore, our model
for N6-2m tetramer shows that the domain-swapped hinge
region found inN6-2m dimer is key to both intra- and inter-
dimer interactions.
Experimental Procedures
Protein Preparation—N6-2m and 2m were expressed in
Escherichia coli and purified using ion exchange chromatogra-
phy and size exclusion chromatography as previously described
(1). Lyophilized protein was dissolved in 100 mM ammonium
acetate, pH 5, before MS analysis.
Ion Mobility-Mass Spectrometry—IM-MS experiments were
performed on a quadrupole ion mobility time-of-flight mass
spectrometer (Synapt HDMS, Waters Corp., Manchester, UK)
modified such that the traveling-wave IM cell is replaced with
an 18-cm drift cell with radial RF confinement (RF amplitude
200 V) and a linear voltage gradient along the axis of ion trans-
mission, as described in detail previously (32). The following
parameters were used: source pressure 4–6 mbar, capillary
voltage 1.0–1.5 kV, sample cone voltage 20V, bias voltage 20V,
IM entrance DC 5 V, trap gas 6 ml min1, trap collision energy
5 V. Helium (2 torr) was used as the buffer gas, and the drift
voltage varied from 50 to 200 V. All spectra were mass-cali-
brated using cesium iodide (100 mg ml1).
Chemical Cross-linkingMS—50l ofN6-2m or 2m were
cross-linked with 10 l of a 25 mM 1:1 mixture of deuterated
(d4) and non-deuterated (d0) bis[sulfosuccinimidyl] suberate
(BS3). The reaction mixture was incubated at 25 °C and 400
rpm for 1 h. 10l of the cross-linked proteins were analyzed by
gel electrophoresis (NuPAGE system, Invitrogen) according to
the manufacturer’s protocol. The proteins were digested in-gel
as described elsewhere (33).
The mixture of cross-linked and non-cross-linked peptides
was analyzed by liquid chromatography-coupled tandem-mass
spectrometry (LC-MS/MS) employing an LTQ-Orbitrap XL
hybrid mass spectrometer (Thermo Scientific) coupled with a
Dionex UltiMate 3000 RSLC nano System (Thermo Scientific).
The peptides were separated by nanoLC (mobile phase A,
0.1% (v/v) formic acid; mobile phase B, 80% (v/v) acetonitrile/
0.1% (v/v) formic acid). The peptides were loaded onto a trap
column (2 cm, HPLC column Acclaim PepMap 100, C18,
100-m inner diameter, particle size 5 m; Thermo Scientific)
and separated on an analytical C18 capillary column (50 cm,
HPLC column Acclaim PepMap 100, C18, 75-m inner diam-
eter particle size 3 m; Thermo Scientific) at a flow rate of 300
nl/min and a gradient of 5–80% (v/v) mobile phase B over 74
min.
The peptides were directly eluted into the mass spectrome-
ter. Mass spectrometric conditions were: spray voltage of 1.8
kV, capillary temperature 180 °C, normalized collision energy
35% at an activation of q 0.25, and an activation time of 30ms.
The LTQ-Orbitrap XL was operated in data-dependent mode.
Survey full scan MS spectra were acquired in the orbitrap (m/z
300–2,000) with a resolution of 30,000 atm/z 400 and an auto-
matic gain control target at 106. The fivemost intense ionswere
selected for collision-induced dissociation in the linear ion trap
at an automatic gain control target of 30,000. Selection of pre-
viously selected precursor ions was dynamically excluded for
30 s. Singly charged ions as well as ions with unrecognized
charge state were also excluded. Internal calibration of the
Orbitrap was performed using the lockmass option (lockmass:
m/z 445.120025) (34).
mzXML files were generated from raw data using the Mass-
Matrix file conversion tool. Potential cross-links were identi-
fied by searching against a reduced database containing
N6-2m and 2m protein sequences using the MassMatrix
Database Search Engine (35). Search parameters were: enzyme,
trypsin; missed cleavage sites, two; variable modifications,
carbamidomethylation of cysteines and oxidation of methio-
nine;mass accuracy filter, 10 ppm for precursor ions and 0.8 Da
for fragment ions; minimum pp and pp2 values, 5.0; minimum
pptag, 1.3; maximum number of cross-links per peptide, 1. All
searches were performed twice, including the deuterated and
the non-deuterated BS3 cross-linker, respectively.
Modeling Restraints from Cross-linking—To test if the iden-
tified cross-links in the N6-2m tetramer (or trimer) were
arising from interdimer or intradimer interactions, we pro-
jected the cross-links confirmed by MS/MS quality onto the
dimer x-ray crystal structure (PDB ID 2X89).Wemeasured the
physical C-C distances (36) to check if these were within
the upper-bound interresidue distance threshold (35 Å) (37). The
cross-links, which do not satisfy our distance threshold, are more
likely to generate from interdimer interactions in the tetramer (or
trimer) and were, therefore, assigned as such in our modeling
analysis. Those that were within the distance threshold were
most likely to arise from intradimer interactions.
MS-based Hybrid Approach—We employed a hybrid ap-
proach for structural determination of oligomeric intermedi-
ates of N6-2m, primarily based on native MS, IM-MS and
cross-linkingMS (CX-MS) (27, 29) (Fig. 1). FromnativeMS, we
established the oligomeric state of the identified complexes
(38). By combiningMS with IM, topological information in the
form of an orientation-averaged collision cross-section (CCS)
was derived (39). The measured CCS from IM-MS was used as
shape restraint for interrogating candidate structural models
Assembling Oligomers ofN6-2-Microglobulin
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(22). CX-MS identified lysines in close proximity and was used
as a distance restraint (27). In addition toMS data, wemade use
of available structures from x-ray crystallography and NMR as
well as EMdensitymaps. The atomic level structures were used
as starting points in our modeling strategy, whereas a segment
of the EM map of 2m assembled into fibrils (EM Database ID
1613; type A) was used as a volume restraint, as there is no
available EM density map for N6-2m fibrils (11). Structural
information obtained from these methods was encoded into
restraints and exploited by a scoring function for subsequent
modeling analysis.
Integrative Modeling and Scoring Function—We generated
structural models of the assemblies by employing a Monte
Carlo search algorithm. The building process was guided by a
scoring function that encoded the experimental data as a sumof
individual restraints. This scoring function (S) evaluates the
ensemble of candidate models generated against their quality-
of-fit with the input data.
S  W IM-MSSIM-MSWCX-MSSCX-MSWEMSEM (Eq. 1)
where SIM-MS and SCX-MS refer to IM-MS and CX-MS re-
straints, respectively. SIM-MS was implemented as a harmonic
potential function (22, 23), whereas SCX-MS was applied as a
distance restraint between two interacting residues (27, 29).
The EM (SEM) restraint assessed the quality-of-fit between the
model and the corresponding molecular volume of an appro-
priate section of the EM map, as defined by the cross-correla-
tion coefficient. IM-MS, CX-MS, and EM were given 1:2:2
weightings (W), respectively, consistent with previous bench-
mark studies (27).
To assess the uniqueness of the ensemble of generated mod-
els we performed ensemble analysis (e.g. clustering of top-scor-
ing solutions), and the final solution was selected from the
major cluster. The visual molecular dynamics (VMD) and
the UCSF Chimera packages were used for visualization of the
structures (40).
CollisionCross-sectionCalculations—To interpret the exper-
imentally obtained CCS values, we compared them to theoret-
ically calculated CCSs (41). Theoretical CCSs were obtained
with the open source MOBCAL code using the projection
approximation (PA) algorithm (42, 43). The PA method is
known to underestimate the experimental CCS of proteins by
neglecting multiple collisions between ions and buffer gas (7,
43). However, it has been shown that it is correlated with the
experimental CCS for protein complexes (R2 0.99) (44). We
use the scaled PA CCS as previously described, where the
experimental CCS can be typically predicted (3%) by multi-
plying the PA CCS by a factor of 1.14 (44). All CCS calculations
include hydrogen atoms.
Molecular Dynamics Simulations—All simulations were per-
formed in single (solution phase) or double floating-point pre-
cision (gas phase) with GROMACS 4.5.3 using the OPLS-AA/L
forcefield (45).
Gas-phase simulations (10 ns) were performed at 300 K as
described previously (46), The MS observed charge state was
distributed evenly over solvent-accessible basic residues (5 Å
from the surface) (47, 48). As such, we assigned the charged
residues for the 6monomer, 9 dimer, 11 trimer, and 13
tetramer charge states of N6-2m. CCSs were calculated for
structures every 25 ps using the scaled PA method imple-
mented in MOBCAL.
FIGURE 1. Integrativemodelingworkflow for structure characterizationof oligomeric protein assemblies. To predict the structures of higher oligomeric
states of proteins,we implement an integrativemodeling strategy. Hereweuse informationderived fromnativeMS, IM-MS, andCX-MS. The acquireddata and
other available information are converted into spatial restraints, which are subsequently utilized by a scoring function to guide the search for candidatemodel
structures. Finally, an analysis step (e.g. clustering) of the top-scoring models determined the most likely structures of the oligomeric assembly pathways.
Assembling Oligomers ofN6-2-Microglobulin
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Solution phase simulations (10 ns) were carried out similarly,
except periodicity and a cutoff of 0.9 and 1.4 nm were used for
electrostatic and van der Waals forces respectively; an integra-
tion step of 2 fs was used. Acidic and basic residues were
charged as appropriate for solution. Total charge of the system
was neutralized by the addition of an appropriate number of
sodium ions.
Software and Scripts—Our integrative protocol was imple-
mented within the open source Integrative Modeling Platform
(IMP) software package.
Results
N6-2m Assembles into Compact Oligomers—We carried
out IM-MS on N6-2m at various monomer concentrations
(10–30 M, pH 5) revealing multiple oligomeric species in
equilibrium (Fig. 2A). Our experiments demonstrated that the
formation of specific oligomers in solution is highly concentra-
tion-dependent (data not shown). At 10 M, the predominant
species observed were monomers and dimers, with a low
amount of trimers formed. At 15 M, we could clearly observe
four charge state distributions corresponding to monomers,
dimers, trimers, and tetramers of N6-2m (Fig. 2A). Higher
concentrations (30 M) revealed higher order oligomers
(pentamer). As a control we carried out similar experiments
using cytochrome c, a monomeric protein of similar molecu-
lar mass (12 kDa). At 15 M and below, only monomeric
species were detected, whereas at higher concentrations (e.g.
30 M), we could observe low intensity peaks for dimeric and
trimeric species (data not shown). Therefore, we carried out
experiments at a protein concentration of 15M tominimize
any contribution from nonspecific aggregation (49). To cor-
rectly assign the oligomeric species of N6-2m, separation
in mobility space was critical, as peaks at certain m/z values
were co-populated with multiple species. For instance, m/z
2800 is composed of both dimer (8 charge state) and trimer
(12 charge state) (Fig. 2A). Separation of different species
with the same m/z but different CCS is a major strength of
IM-MS.
CCS measurements were performed for all charge states of
the four oligomers observed forN6-2m (15M). Arrival time
distributions (ATD) had Gaussian peak shapes with tD/tD 	
11–12, consistent with a single conformer or group of closely
related conformations (representative ATDs are shown in Fig.
2C) (39). The CCS deviation between different charge states of
a particular oligomer was typically 5% (considered to be
within experimental error), and we therefore averaged the CCS
FIGURE 2. IM-MS data and coarse-grainedmodeling reveal a compact tetrameric intermediate inN6-2m aggregation. A, IM-MS ofN6-2m (15M,
pH 5) revealed four charge state distributions, corresponding to the 1-mer, 2-mer, 3-mer, and 4-mer. B, IM-MS of full-length 2m (15 M, pH 5) reveals charge
state distributions corresponding to 1-mer and 2-mer. Higher order oligomers up to tetramer could be observed at higher protein concentrations (30M, not
shown). C, representative arrival time distributions for the 4-mer (12), 3-mer (11), 2-mer (9), and 1-mer (6) of N6-2m. D, the N6-2m tetramer was
assembled from themonomer by the stepwise addition of subunits using a coarse-grainedmodeling strategy. Themodel with lowest score at each stagewas
chosen as the starting point for the subsequent addition of further monomer units. E, manual fitting of the low resolution N6-2m tetramer (best scored
model after clustering) into the cryo-EM density map of 2m fibrils (EM Database ID 1613). Segments (red box) of the EMmap are shown as surface-and-mesh
representations in three different orientations.
Assembling Oligomers ofN6-2-Microglobulin
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across all measured charge states. The average CCS for mono-
mer (CCSexp, 1200  36 Å2), dimer (CCSexp, 1900  57 Å2),
trimer (CCSexp, 2530  76 Å2), and tetramer (CCSexp, 3057 
92 Å2) were measured (Table 1).
We applied a similar approach to interrogate full-length
2m, which is expected to oligomerize to a lesser extent than its
truncated variant at pH 5 (19). We observed monomer and
dimer at a protein concentration of 15 M (Fig. 2B), with trim-
ers and tetramers only observed at higher concentrations (30
M, data not shown). We measured CCSs for the oligomers of
2m at 15 M (monomer and dimer) and at 30 M (trimer and
tetramer) (Table 1) revealing values 5% greater than those
measured for N6-2m, consistent with the higher molecular
weight. This suggests that the oligomers of full-length 2m and
its truncated variant adopt similar conformations for their early
oligomeric intermediates.
To establish the overall topology (i.e. compact or elongated)
of N6-2m oligomers, we used the IM-MS data to inform a
coarse-grained modeling strategy reported previously (22).
Monomers were represented as spheres, with radii defined by
the monomer CCS. Models were then built for the dimer and
trimer by varying the intersubunit distances and angles. These
models were then scored, and the one with the lowest total
score at each stagewas taken to the next step, to form the (n1)
oligomer (Fig. 2D). To sample conformational space for the
tetramer, a Monte Carlo approach was used keeping the rela-
tive position of the three other subunits fixed. The 1% lowest
scoringmodels were clustered, revealing three distinct clusters.
The largest cluster (84.4%) is represented by a compact topo-
logical arrangement of subunits. This low resolution model of
tetrameric N6-2m from IM-MS is consistent with a recently
published EMmap of 2m fibrils (Fig. 2E).
Protein Interactions in N6-2m Oligomers—Next, we
employed CX-MS to gain insights into the interprotein inter-
actions at atomic level.N6-2mwas incubatedwith a 1:1mix-
ture of non-deuterated (d0) and deuterated (d4) BS3. The cross-
linked proteins were separated by gel electrophoresis (Fig. 3A).
The bands corresponding to monomer, dimer, trimer, and
tetramer of N6-2m were cut, and the proteins were digested
FIGURE 3. Cross-linking of N6-2m and 2m. A, N6-2m and 2m were cross-linked with a 1:1 mixture of BS3-d0/d4. The gels show the presence of
monomers, dimers, trimers, and tetramers. B, cross-links were verified by the presence of peak pairs in themass spectra corresponding to light (d0) and heavy
(d4) cross-linked peptides. C, cross-linked dipeptides containing the same or overlapping peptide sequences are unambiguously assigned to interprotein
cross-links. An example spectrum is shown.
TABLE 1
IM-MS experiments showed similar measured CCS for oligomeric spe-
cies ofN6-2m (15M, pH 5) and full-length 2m (15–30M, pH 5)
Oligomeric species
N6-2m 2m
CCS Error CCS Error
Å2 Å2
Monomer 1200 36 1250 13
Dimer 1900 57 1994 20
Trimer 2530 76 2622* 52
Tetramer 3057 92 3213* 64
a CCS measurement at 30 M.
Assembling Oligomers ofN6-2-Microglobulin
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TABLE 2
Identified cross-links forN6-2m and 2m oligomers
Peptide sequence 1 Peptide sequence 2 Residue 1 Residue 2 No. spectra
N6-2m monomer
VNHVTLSQPKIVK H2N-IQVYSR 110 27 6
VNHVTLSQPKIVKWDRDM 110/113 64
VNHVTLSQPKIVKWDR 110/113 29
N6-2m dimer
VNHVTLSQPKIVK IVKWDR 110 113 2
VNHVTLSQPKIVK IVKWDRDM 110 113 4
VNHVTLSQPKIVK H2N-IQVYSR 110 27 4
VNHVTLSQPKIVK VNHVTLSQPKIVK 110 110 13
IEKVEHSDLSFSK IVKWDRDM 67 113 1
VNHVTLSQPKIVKWDR 110/113 40
VNHVTLSQPKIVKWDRDM 110/113 44
IEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACR 67/77 1
N6-2m trimer
VNHVTLSQPKIVKWDR IVKWDR 110 113 1
VNHVTLSQPKIVKWDR IVKWDRDM 110 113 1
VNHVTLSQPKIVK IVKWDR 110 113 2
VNHVTLSQPKIVK IVKWDRDM 110 113 4
VNHVTLSQPKIVK H2N-IQVYSR 110 27 6
IEKVEHSDLSFSK VNHVTLSQPKIVK 67 110 2
IEKVEHSDLSFSK IEKVEHSDLSFSK 67 67 1
VNHVTLSQPKIVK VNHVTLSQPKIVK 110 110 9
VNHVTLSQPKIVKWDR 110/113 23
VNHVTLSQPKIVKWDRDM 110/113 24
N6-2m tetramer
VNHVTLSQPKIVK IVKWDR 110 113 2
VNHVTLSQPKIVK IVKWDRDM 110 113 2
VNHVTLSQPKIVK H2N-IQVYSR 110 27 2
IEKVEHSDLSFSK VNHVTLSQPKIVK 67 110 2
VNHVTLSQPKIVK VNHVTLSQPKIVK 110 110 7
VNHVTLSQPKIVKWDR 110/113 15
VNHVTLSQPKIVKWDRDM 110/113 15
2m monomer
VNHVTLSQPKIVK TPKIQVYSR 110 26 84
VNHVTLSQPKIVKWDRDM TPKIQVYSR 110 26 8
VNHVTLSQPKIVKWDR TPKIQVYSR 110 26 3
VNHVTLSQPKIVKWDR TPKIQVYSR 113 26 2
VNHVTLSQPKIVKWDR 110/113 40
VNHVTLSQPKIVKWDRDM 110/113 62
2m dimer
H2N-IQRTPKIQVYSR TPKIQVYSR 21 26 3
IQRTPKIQVYSR TPKIQVYSR 26 26 3
TPKIQVYSR TPKIQVYSR 26 26 20
IEKVEHSDLSFSK TPKIQVYSR 67 26 2
IEKVEHSDLSFSK VNHVTLSQPKIVK 67 110 1
VNHVTLSQPKIVK TPKIQVYSR 110 26 71
VNHVTLSQPKIVK VNHVTLSQPKIVK 110 110 6
VNHVTLSQPKIVK IVKWDRDM 110 113 1
VNHVTLSQPKIVKWDRDM TPKIQVYSR 110 26 4
IVKWDRDM TPKIQVYSR 113 26 1
VNHVTLSQPKIVKWDR TPKIQVYSR 113 26 1
VNHVTLSQPKIVKWDR TPKIQVYSR 113 26 3
VNHVTLSQPKIVKWDR 110/113 30
VNHVTLSQPKIVKWDRDM 110/113 41
2m trimer
VNHVTLSQPKIVK TPKIQVYSR 110 26 50
VNHVTLSQPKIVKWDR TPKIQVYSR 113 26 3
VNHVTLSQPKIVKWDRDM TPKIQVYSR 110 26 2
TPKIQVYSR TPKIQVYSR 26 26 9
IQRTPKIQVYSR TPKIQVYSR 26 26 1
IEKVEHSDLSFSK VNHVTLSQPKIVK 67 110 2
IEKVEHSDLSFSK TPKIQVYSR 67 26 2
VNHVTLSQPKIVK VNHVTLSQPKIVK 110 110 7
VNHVTLSQPKIVKWDR 110/113 16
VNHVTLSQPKIVKWDRDM 110/113 26
2m tetramer
VNHVTLSQPKIVK TPKIQVYSR 110 26 30
TPKIQVYSR TPKIQVYSR 26 26 8
IEKVEHSDLSFSK TPKIQVYSR 67 26 4
VNHVTLSQPKIVK VNHVTLSQPKIVK 110 110 5
VNHVTLSQPKIVKWDR 110/113 19
VNHVTLSQPKIVKWDRDM 110/113 25
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with trypsin. The mixture of peptides and cross-linked dipep-
tides for each band were analyzed by LC-MS/MS. In total, we
obtained 138 potential hits after database searching, of which
we validated 92 spectra by (i) the presence of peak pairs in the
MS spectra (corresponding to BS3-d0 and d4; Fig. 3B) and (ii) by
the quality of tandem-MS spectra, resulting in a false discovery
rate of 33.33% (Table 2).
Importantly we obtained dipeptides with the same or over-
lapping peptide sequences in the dimer, trimer, and tetramer
bands, allowing their unambiguous classification as interpro-
tein cross-links (Fig. 3C). The remaining cross-links are diffi-
cult to assign to intra- or interprotein cross-links, as the oligo-
mers are formed by monomers with the same amino acid
sequence, and their peptide sequences are not unique.Wehave,
therefore, excluded these cross-links from our modeling and
only implemented cross-links that were unique and unambig-
uously related to interprotein interactions.
To assess the structural differences between full-length 2m
and its truncated form, we performed cross-linking experi-
ments on 2m following the same strategy as above. Bands cor-
responding to monomer, dimer, trimer, and tetramer of 2m
were cut, proteinswere digested, and peptideswere analyzed by
LC-MS/MS. We obtained 529 potential hits after database
searching and validated 322 of these manually (false discovery
rate 39.13%). We obtained two unique cross-links from the
monomer band and up to nine unique cross-links for the dimer,
trimer, or tetramer bands (Table 2). These cross-links were in
good agreement with those obtained for N6-2m (Table 2).
Due to the longer amino acid sequence in 2m we identified
additional interactions in theN-terminal regions of the protein.
Thehigh similarity between theobserved cross-links in theolig-
omers of the two variants suggests highly conserved solution
structures and initial assembly mechanism.
Building Atomic Models of N6-2m Oligomers—Having
established N6-2m interresidue proximities from CX-MS
and the overall compact assembly using IM-MS, we turned our
attention to identify suitable atomic resolution structures from
the protein data bank (PDB) for building furtherN6-2molig-
FIGURE 4.Workflow for structural characterization ofN6-2m tetramer. A, structural data from IM-MS and CX-MSwere used to select a suitable starting
structure for building the tetramer. The cross-linking data (orange) was consistent withN6-2mmonomer NMR (PDB ID 2XKU) and dimer x-ray (PDB ID 2X89)
crystal structures. Calculated CCS for the energy-minimizedmonomerwas in good agreement with experimental CCS from IM-MS; however, calculated dimer
CCS was larger than observed experimentally. B, gas-phase MD simulations were performed on the dimer, and the subsequently calculated CCS was in good
agreementwith experimental CCS, suggesting subtle compaction in thegasphase. Informationon the trimer from IM-MSandcross-linkingMSwere combined
using a scoring function in an integrative approach to suggest model structures for trimeric N6-2m, starting from the validated monomer and dimer
structures fromNMR and x-ray crystallography, respectively. Gas-phaseMD simulationswere performed on the best-scoring trimericmodel structure and CCS
calculated, showing good agreement with experimental CCS. C, similarly, using restraints from IM-MS, cross-linking MS and EM model structures were
suggested for tetramericN6-2m, starting from the validated dimeric structure (1). Docking of the best-scoring tetramermodel into the2m fibril EMdensity
map (EM Database ID 1613) showed excellent agreement, with a cross-correlation coefficient of 0.77.
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omers. NMR structure (PDB ID 2XKU) for N6-2m mono-
mer (50) was used to compare the calculated monomer CCS
with that from IM-MS. These were found to differ by 6.3%
(CCSexp 1200 36Å2;CCScalc 1276Å2). Rearrangements in the
gas phase are thought to be responsible for overall compaction
of the structure in the absence of solution leading to lower
experimental CCS values than anticipated from the crystal
structure (51). To account for this possibility, gas-phasemolec-
ular dynamics (MD) simulations were performed before CCS
calculations (46). The calculated CCS of the simulated struc-
ture was in good agreement with the measured CCS (CCSexp
1200 36 Å2; CCScalc 1144 Å2; 4.5% deviation). Next, we pro-
jected the experimentally identified cross-links (Table 2) onto
the atomic structure and measured the C-C distances (Fig.
4A). The calculated distances revealed that the experimentally
determined cross-links were in good agreement with the NMR
structure using an upper bound interresidue distance threshold
of 35 Å (27).
X-ray crystal structure (PDB ID 2X89) is composed of two
N6-2m monomers associated through domain-swapping.
We compared the calculated CCS from this structure with the
measured dimer CCS from IM-MS and found them to differ by
8% (CCSexp 1900  57 Å2; CCScalc 2064 Å2). Similar to the
monomer, we carried out gas-phaseMD simulations and found
that the calculated CCS of the simulated dimer was in good
agreement with the measured CCS from IM-MS (CCSexp
1900 57 Å2; CCScalc 1873 Å2; 1.4% deviation) (Fig. 4B). Struc-
tural rearrangement in the gas phase primarily occurred
through the compaction of the gross structure as measured by
center of mass distances between the two interacting mono-
mers, which decreased from 2.93 to 1.97 nm during the MD
simulation. Structural agreementwith the experimentally iden-
tified cross-links (Table 2) was confirmed by projecting them
onto the x-ray crystal structure before and after the MD
simulations.
Overall we conclude that both the NMR structure for the
N6-2m monomer and the x-ray structure for the dimer are
consistent with our experimental data and are themselves
structurally similar (Fig. 5, A and B). We, therefore, used these
structures as a starting point to build higher order oligomers.
Of particular interest is the dimeric structure, as domain-swap-
ping has been proposed as a plausible assembly mechanism for
amyloidogenesis (1, 9).
IntegrativeModeling PredictsN6-2mOligomers at Atomic
Resolution—Having validated starting structures for building
higher oligomers, we used an integrative approach to model
trimeric and tetrameric N6-2m. To achieve this we compu-
tationally integrated our MS data (trimer and tetramer) with
available information from EM (tetramer only) using a suitable
scoring function (“Experimental Procedures”).
We began by building a model for trimeric N6-2m at
atomic resolution. We used as starting structures the domain-
FIGURE 5. Starting structures and interaction interfaces for tetrameric N6-2m. A, N6-2m monomer was reconstructed from the domain-swapped
dimer x-ray crystal structure (PDB ID 2X89) by extracting the coordinates manually and subsequently rebuilding a missing loop using MODELLER. B, the
reconstructed monomer shows striking similarity with the monomeric N6-2m structure determined by NMR (PDB ID 2XKU). Colored regions show the
corresponding-sheets A toG in the two structures.C, model structure ofN6-2m tetramer reveals that intradimeric interfaces are formedby the interaction
of the domain-swapped hinge regions and on the opposite side, the D strands interact through hydrogen bonding between Glu-50 and Ser-52. The interdi-
meric interface is formed fromthe interactionof thedomain-swappedhinge regionsbyhydrogenbondingof Ser-88 (chainD), Thr-86, andSer-88 (chainC)with
Thr-86 (chain B), Ser-88, and Gln-89 (chain A). Hydrogen bonds were identified using the HBonds tool in VMD (visual molecular dynamics).
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swapped dimer and the monomer from NMR. We generated
10,000 atomicmodels using aMonte Carlo sampling of confor-
mational space, and themodels generated were evaluated using
the scoring function described above. In particular, we scored
all models using the experimentally measured CCS (CCSexp
2530 Å2) and four interdimer cross-links, K110:K113 (19.5 Å)
K110:K110 (13.4 Å), K110:K67 (29.3 Å), andK110:K27 (18.0 Å),
identified in the trimer band (Table 2). Clustering analysis of
the top-scoring 1% models revealed two main clusters (thresh-
old 5 Å). We chose a representative structure of the largest
cluster (60%). We finally performed gas phase MD simulations
(46) showing a compaction (10%; CCScalc 2640 Å2) of the trim-
eric structure in vacuum (Fig. 4B), in good agreement with the
measured CCS (4% deviation).
Next, we employed a similar strategy to predict the most
likely architecture of the tetrameric N6-2m, starting with
two dimers (Fig. 4C). We scored all models using the experi-
mentally measured CCS (CCSexp 3057 Å2), the three identified
interdimer cross-links, K110:K113 (22.3 Å), K110:K110 (20.9
Å) and K110:K67 (32.4 Å), for the tetramer (Table 2), and the
section of density map corresponding to the globular tetramer
of 2m (EM Database ID 1613) (11). To reflect the molecular
envelope of tetrameric N6-2m, we chose a globular rather
than elongated section from the EM map (Fig. 4C), consistent
with our IM-MS experiments and coarse-grained modeling
(Fig. 2E). As performed on the trimer, the top 1% scoring mod-
els for the tetramerwere clustered, and the top scoringmodel in
the largest cluster was chosen as the representative model
structure (Fig. 4C). Interestingly, in this model the hinge region
consisting of heptapeptides NHVTLSQ, which readily form
amyloids in isolation, are stacked together (Fig. 5C). These
interact through dimer-dimer interfaces by hydrogen bonding
between Ser-88 (D chain), Thr-86 and Ser-88 (C chain) from
one dimer with Thr-86, Ser-88, and Gln-89 from a second
dimer, respectively (Fig. 5C). Of further interest are the D
strands, dynamic regions which are thought to play a role in
amyloidogenicity (2, 52). Here, these form the dimer interface
on the opposite side to the domain-swapped hinge region (Fig.
5C).
Finally, to assess the stability of the predicted tetramer, we
performed solution and gas phase MD simulations (46). These
simulations revealed that the tetramer underwent only subtle
changes over the simulation timeframe, suggesting a stable
conformation (Fig. 6, A and B).
Discussion
N6-2m oligomers have been proposed as intermediate
assemblies leading to fibrillogenesis either through nucleation
and elongation of their own fibrils or through cross-seeding
with full-length 2m (2). 2m fibrillogenesis may be seeded by
preformed N6-2m filaments or fibrils (53). Alternatively,
N6-2m monomers may interact with full-length 2m, ena-
bling a transition into an aggregation-prone conformation (50).
Evidence in support of this, from NMR (50) and IM-MS (18),
shows that 2m monomers undergo a conformational change
before oligomerization. This intermediate state is thought to
have enhanced amyloidogenic potential (2). A similar interme-
diate state may be more readily accessible for N6-2m, giving
rise to its increased amyloidogenicity compared with full-
length 2m (2, 54, 55). Another possibility is that a proteolytic
step may precede aggregation, in which the N-terminal hexa-
peptide is removed from 2m and that N6-2m is, therefore,
itself an on-pathway intermediate of 2m fibrillation (54).
Although the specific interaction between 2m and N6-2m
remains a topic of intense debate, it is becoming increasingly
clear that studying the early oligomeric pathway ofN6-2m at
atomic levelmay be essential to understand the assemblymech-
anism for full-length 2m.
Here we predict structural models and an early assembly
mechanism for oligomers of N6-2m up to tetramer, high-
lighting their compact topologies and key intersubunit interac-
tions and comparing oligomers of the full-length protein.
Because fibrillogenesis has been observed for N6-2m under
similar solution conditions to those used in our MS experi-
ments (1), we believe that the observed oligomers serve as pre-
amyloid intermediates en route to higher order oligomeric spe-
cies and fibril formation.
From our comparative IM-MS andCX-MS results, we estab-
lished that N6-2m and full-length 2m had similar oligomer
profiles, CCS, and identified cross-links. This suggests a high
structural similarity for the lower order oligomers of these two
variants and points to a conserved initial assembly mechanism
FIGURE 6.MD simulations onN6-2m tetramer. A, gas-phaseMD simula-
tions of N6-2m tetramer revealed subtle structural rearrangement mea-
suredbyadecrease inCCS (	5.9%;gray line) over the courseof the simulation
(10 ns). B, solution phase MD simulations of N6-2m tetramer revealed an
overall stable conformation as measured by the moderate root mean square
deviation (RMSD, black line) over 25 ns.
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before fibrillogenesis. The specific experimental conditions,
however, are important for determining the ex vivo aggregation
pathway followed and resulting fibril morphology (18, 19, 56).
Previous studies of full-length 2m have shown that at low pH
and low ionic strength, long straight fibrils are formed via a
nucleated mechanism. On the other hand, at higher pH and
ionic strength, worm-like fibrils are formed, with elongation
proceeding via a non-nucleated, monomer addition pathway,
and a conformational change in monomeric 2m thought to be
responsible for initiating oligomerization. Interestingly, assem-
bly of 2m in the presence of Cu(II) ions proceeds through
dimer addition (52), with domain-swapping also implicated
(57).
Although the precise assembly mechanism(s) followed in
vivo are not fully understood, the evidence is growing for a
domain-swapped oligomeric intermediate preceding fibril for-
mation (1, 9). By exploiting the power of MS, we put forward a
model at the atomic level of resolution, describing the early
formation ofN6-2m oligomers, indicating a stepwise assem-
bly mechanism through the addition of monomeric subunits
(Fig. 7A). We further mapped the oligomeric growth into the
fibrillar EMmap to show the conversion of stacked domain- to
runaway-swapped oligomers in which the ends of the growing
oligomers are capable of binding open monomers by self-tem-
plated growth (Fig. 7B). Overall, this study provides novel
insights into the early mechanism of pre-amyloid assemblies
and further makes inroads toward an atomic level description
of 2m that entails detailed structural models of intermediate
states and their associated transient interactions.
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